Successful long-term prophylaxis of hereditary pregnancy-associated angioedema with plasma-derived C1-inhibitor concentrate: a case report
Hereditary angioedema (HAE) is a rare autosomal dominant disease caused by quantitative (type I) or functional (type II) deficiency in C1 esterase inhibitor (C1-INH). It may be caused by new mutations in up to 20% of patients. Prevalence of HAE is uncertain but is estimated to be approximately 1 cas...
Guardado en:
Autores principales: | D. V. Demina, A. O. Makeeva, L. M. Kudelya, E. V. Novikova, V. A. Kozlov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a617cd7e7034474885922215c2a67835 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oxidative stress markers in patients with hereditary angioedema
por: Stefano R. Del Giacco, et al.
Publicado: (2018) -
Subclinical Signs of Retinal Involvement in Hereditary Angioedema
por: Paola Triggianese, et al.
Publicado: (2021) -
Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
por: Daniel F. Soteres, et al.
Publicado: (2021) -
Significance of individual management plan for the patients with hereditary lymphangioedema during pregnancy and lactation, and in newborns
por: E. N. Bobrikova, et al.
Publicado: (2020) -
Angioedema cervical
por: VALENZUELA V,CATALINA, et al.
Publicado: (2008)